Sprycel and Malabsorption - a phase IV clinical study of FDA data

Summary:

Malabsorption is reported as a side effect among people who take Sprycel (dasatinib), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Fish Oil, and have Myeloid leukaemia.

The phase IV clinical study analyzes which people have Malabsorption when taking Sprycel. It is created by eHealthMe based on reports of 29,638 people who have side effects when taking Sprycel from the FDA, and is updated regularly.

What is Sprycel?

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.

What is Malabsorption?

Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract) is found to be associated with 694 drugs and 1,091 conditions by eHealthMe. Check the latest studies of Malabsorption.

On Jan, 27, 2026

29,638 people reported to have side effects when taking Sprycel.
Among them, 11 people (0.04%) have Malabsorption.

Among these 11 people:

How long have people been on Sprycel when they have Malabsorption? *

What is the gender of people who have Malabsorption when taking Sprycel? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Malabsorption when taking Sprycel? *

What are other drugs people take besides Sprycel? *

What are other side effects people have besides Malabsorption? *

Gastric Disorder (disease of stomach): 3 people, 27.27%
Weight Increased: 2 people, 18.18%
Migraine (headache): 2 people, 18.18%
Fatigue (feeling of tiredness): 2 people, 18.18%
Flatulence (flatus expelled through the anus): 2 people, 18.18%
Fungal Infection: 2 people, 18.18%
Hypoglycemia (low blood sugar): 2 people, 18.18%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 18.18%
Joint Pain: 2 people, 18.18%
Insomnia (sleeplessness): 2 people, 18.18%

What are the existing conditions these people have? *

Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 18.18%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 9.09%
Leukaemia (blood or bone marrow cancer): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sprycel and have Malabsorption?

- Check whether Malabsorption is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sprycel:

Sprycel (29,788 reports)

Malabsorption treatments and more:

Malabsorption (8,910 reports)

Browse all side effects of Sprycel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malabsorption:

Malabsorption (694 drugs)

Browse all the conditions that are associated with Malabsorption:

Malabsorption (1,091 conditions)

Drugs similar to Sprycel and Malabsorption :

Gleevec side effect: Malabsorption

How the study uses the data?

The study uses data from the FDA. It is based on dasatinib (the active ingredients of Sprycel) and Sprycel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.